-
Cumberland Pharmaceuticals Inc. v. Mylan Institutional LLC et al DC CAFC
- 1:12-cv-03846
- N.D. Ill.
- Judge: Rebecca R. Pallmeyer
- Filed: 05/17/2012
- Closed: 11/17/2015
- Latest Docket Entry: 08/29/2019
- PACER
- Docket updated daily
1
Plaintiff
2
Defendants
2
Accused
Products
2
Patents-in-Suit
1,280
Days in
Litigation
-
Cumberland Pharmaceuticals Inc. v. Mylan Institutional LLC et al DC CAFC
- 1:12-cv-03846
- N.D. Ill.
- Judge: Rebecca R. Pallmeyer
- Filed: 05/17/2012
- Closed: 11/17/2015
- Latest Docket Entry: 08/29/2019
- PACER
- Docket updated daily
Market Sector
Biotech and Pharma
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
Claim # | Claim Text | Outcome |
---|---|---|
1 |
A method of treating acetaminophen overdose, comprising: using a stable aqueous pharmaceutical composition comprising 200 mg/ml acetylcysteine or pharmaceutically acceptable salts thereof, wherein the composition is free of chelating agents, wherein
view more
|
Enforceable and Valid
Entry 340 |
2 |
The method of claim 1, wherein the aqueous solution comprises at least one of 5% dextrose, 0.45% sodium chloride, and water for injection.
|
Enforceable and Valid
Entry 340 |
3 |
The method of claim 1, wherein the diluted composition is administered as a loading dose of 150 mg/kg, followed by a second dose of 50 mg/kg, followed by a third dose of 100 mg/kg.
|
Enforceable and Valid
Entry 340 |
4 |
The method of claim 1, wherein the total dose of diluted composition administered is 300 mg/kg.
|
Enforceable and Valid
Entry 340 |
5 |
The method of claim 1, wherein the pH of the composition is from 6.0 to less than 7.0.
|
Enforceable and Valid
Entry 340 |
6 |
A method of treating acetaminophen overdose, comprising: using a stable aqueous pharmaceutical composition comprising from 200 mg/ml to 250 mg/ml acetylcysteine or pharmaceutically acceptable salts thereof, wherein the composition is free of
view more
|
Enforceable and Valid
Entry 340 |
7 |
The method of claim 6, wherein the aqueous solution comprises at least one of 5% dextrose, 0.45% sodium chloride, and water for injection.
|
Enforceable and Valid
Entry 340 |
8 |
The method of claim 6, wherein the diluted composition is administered as a loading dose of 150 mg/kg, followed by a second dose of 50 mg/kg, followed by a third dose of 100 mg/kg.
|
Enforceable and Valid
Entry 340 |
9 |
The method of claim 6, wherein the total dose of diluted composition administered is 300 ma/ka.
|
Enforceable and Valid
Entry 340 |
10 |
A method of treating acetaminophen overdose-induced liver damage, comprising: using a stable aqueous pharmaceutical composition comprising 200 mg/ml acetylcysteine or pharmaceutically acceptable salts thereof, wherein the composition is free of
view more
|
Enforceable and Valid
Entry 340 |
11 |
The method of claim 10, wherein the pH of the composition is from 6.0 to less than 7.0.
|
Enforceable and Valid
Entry 340 |
12 |
The method of claim 10, wherein the aqueous solution comprises at least one of 5% dextrose, 0.45% sodium chloride, and water for injection.
|
Enforceable and Valid
Entry 340 |
13 |
The method of claim 10, wherein the diluted composition is administered as a loading dose of 150 mg/kg, followed by a second dose of 50 mg/kg, followed by a third dose of 100 mg/kg.
|
Enforceable and Valid
Entry 340 |
14 |
The method of claim 10, wherein the total dose of diluted composition administered is 300 mg/kg.
|
Enforceable and Valid
Entry 340 |
-
Infringement
Mylan Incorporated
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Acetadote formulationGeneric acetadote formulation | US 8,399,445 B2 |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
|
Infringement
Entry 340Entry 316 |
Mylan Institutional LLC
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Acetadote formulationGeneric acetadote formulation | US 8,399,445 B2 |
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
|
Infringement
Entry 340Entry 316 |